$8M Seed Funding, $6M Additional Capital Secured; Unveils Enhanced Quality of Life Platform
With strong growth projected for the global HealthTech apps market, Brazilian created MedPass is firmly on the leading edge of this wave as it gains significant traction with investors and clients alike.
MedPass – which currently targets corporate employees – today unveiled a substantially enhanced version of its HealthTech platform, 4.0, as it reports additional strong investor backing: After earlier securing $8 million in seed funding since 2016, it now has commitments from investors for another funding round of $6 million to finance the company’s continuing growth.
In Brazil’s highly fragmented healthcare startup market, with over 500 registered companies listed on Crunchbase, just 30 firms have received more than $1 million in seed funding, and a mere 10 have been funded above $5 million – and MedPass is one of them.
Introduction to MedPass HealthTech Platform